Global Fractional Flow Reserve market analysis
Overview
The FFR (fractional flow reserve) method is used to calculate the blood pressure differential through stenosis in coronary arteries (blockage). The FFR is used to decide whether or not angioplasty is needed. This procedure is used during the angiography process to assess the amount of oxygen provided to the heart as a result of the blockage (stenosis). The pressure after a stenosis compared to the pressure before the stenosis is known as fractional flow reserve. A sheath and guide-wire are used to insert a catheter into the femoral or radial arteries during coronary catheterization. The wire has a transducer on the tip that monitors blood pressure, temperature, and flow in order to assess the magnitude of the blockage.
Get Your FREE Sample Copy of the Fractional Flow Reserve Market Report 2021
Drivers
The manufacturing of drugs for the treatment of coronary heart disease is a lucrative business for leading manufactures (CHD). In May 2019, Phillips released Instant Wave Free Ratio, a tweaked variant of the currently available FFR on the market. This new formulation eliminates the need for adenosine, which is often used in FFR to cause hyperemia in patients.
In addition, in 2014, Heartflow introduced an FFR-embedded new cardiac CT scanner, which enabled patients to avoid invasive testing during cardiac catheterization. Furthermore, in November 2019, Opsens, Inc. released “Optowire,” a guide wire with optic sensing technology. In December 2018, CathWorks, a Japanese firm, obtained regulatory approval from the US FDA for FFRangio, a non-invasive FFR technique.
In 2017, coronary heart disease (CHD) claimed the lives of 365, 914 people worldwide, according to the CDC (Centers for Disease Control and Prevention). Furthermore, according to the same source, 18.2 million individuals above the age of 20 worldwide suffer from CHD, with 2 in 10 deaths occurring in people under the age of 65. Unhealthy lifestyle choices, such as eating foods rich in salt and fat, reducing physical exercise, smoking, and consuming alcohol, can all contribute to the development of CHD.
Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/3373
According to the American Heart Association’s 2016 Heart Disease and Stroke Statistics survey, about 15.5 million people in the United States had CHD in 2016. The same source continues that CHD affects 37.5 percent of men and 18.3 percent of women. During the forecast period, these trends are expected to propel the global fractional flow reserve market forward.
Restraints
As per the study from the (ACC American College of Cardiology) from 2017, patients should not use FFR because of the high cost of the guidewire, the more time it takes to perform the FFR treatment, the lower supply of adenosine, and the fact that using adenosine as a stressor during the FFR procedure leaves some patients nervous.
The high-income regions such as Western Europe and North America commonly use FFR in CHD patients, while low-income regions such as Africa, Asia Pacific, Latin America, and the Middle East do not use this method often.
Ask for PDF sample copy of the Fractional Flow Reserve market report
Regional Analysis
During the forecast period, North America is predicted to maintain its dominance in the global fractional flow reserve market. The demand in North America is growing due to factors such as the rising prevalence of cardiovascular diseases that necessitate surgical action. CHD affected about 15.5 million people in the United States in 2016, according to the NCBI (National Center for Biotechnology Information). Since the United States is classified as a high-income region, the mortality rate of patients suffering from CHD is projected to decrease as a result of the use of new technology such as FFR in medical treatment.
Furthermore, low-income areas such as Asia Pacific, the Middle East, and Latin America have a higher rate of coronary heart disease deaths. According to a survey published by the WHO (World Health Organization) in 2016, cardiovascular diseases account for half of all deaths in Europe. According to the NCBI (National Center for Biotechnology Information), nearly 1,000,000 cardiac catheterization procedures are conducted per year around the world in 2019. As a result, the launch of current, as well as new treatment solutions across North America and Europe, is projected to drive growth in the global fractional flow reserve market over the forecast period.
Key Players
Major companies contributing in the global fractional flow reserve market are Opsens Inc., GE Healthcare, Boston Scientific Corporation, Pie Medical Imaging BV, Abbott Laboratories, Medtronic plc, Cathworks Ltd., Koninklijke Philips N.V., Heartflow, and ACIST Medical Systems, Inc.
Market Segmentation
According to the type of product
- Instrument
- Invasive
- Non-invasive
- Accessories
According to technology
- Fractional Flow Reserve
- Instant Wave Free Ratio
According to the end-user
- Hospitals
- Ambulatory Surgical Centre
- Cardiovascular Clinics
According to region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/3373
Main points in Fractional Flow Reserve Market Report Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Fractional Flow Reserve Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Fractional Flow Reserve Industry Impact
Chapter 2 Global Fractional Flow Reserve Competition by Types, Applications, and Top Regions and Countries
2.1 Global Fractional Flow Reserve (Volume and Value) by Type
2.3 Global Fractional Flow Reserve (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Fractional Flow Reserve Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Fractional Flow Reserve Market Analysis
Chapter 6 East Asia Fractional Flow Reserve Market Analysis
Chapter 7 Europe Fractional Flow Reserve Market Analysis
Chapter 8 South Asia Fractional Flow Reserve Market Analysis
Chapter 9 Southeast Asia Fractional Flow Reserve Market Analysis
Chapter 10 Middle East Fractional Flow Reserve Market Analysis
Chapter 11 Africa Fractional Flow Reserve Market Analysis
Chapter 12 Oceania Fractional Flow Reserve Market Analysis
Chapter 13 South America Fractional Flow Reserve Market Analysis
Chapter 14 Company Profiles and Key Figures in Fractional Flow Reserve Business
Chapter 15 Global Fractional Flow Reserve Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837